Standard
Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada : A longitudinal cohort study. / Morrow, Richard; Mintzes, Barbara; Souverein, Patrick; Hallgreen, Christine; Ahmed, Bilal; Roughead, Elizabeth; De Bruin, Marie Louise; Kristiansen, Sarah; Lexchin, Joel; Kemp-Casey, Anna; Sketris, Ingrid; Mangin, Dee; Pearson, Sallie-Anne; Puil, Lorri; Lopert, Ruth; Bero, Lisa; Gnjidic, Danijela; Sarpatwari, Ameet; Dormuth, Colin.
In:
Pharmacoepidemiology and Drug Safety, Vol. 31, No. S2, 2022, p. 76-76.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Morrow, R, Mintzes, B, Souverein, P, Hallgreen, C, Ahmed, B, Roughead, E, De Bruin, ML, Kristiansen, S, Lexchin, J, Kemp-Casey, A, Sketris, I, Mangin, D, Pearson, S-A, Puil, L, Lopert, R, Bero, L, Gnjidic, D, Sarpatwari, A & Dormuth, C 2022, 'Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study', Pharmacoepidemiology and Drug Safety, vol. 31, no. S2, pp. 76-76.
APA
Morrow, R., Mintzes, B., Souverein, P., Hallgreen, C., Ahmed, B., Roughead, E., De Bruin, M. L., Kristiansen, S., Lexchin, J., Kemp-Casey, A., Sketris, I., Mangin, D., Pearson, S-A., Puil, L., Lopert, R., Bero, L., Gnjidic, D., Sarpatwari, A., & Dormuth, C. (2022). Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study. Pharmacoepidemiology and Drug Safety, 31(S2), 76-76.
Vancouver
Morrow R, Mintzes B, Souverein P, Hallgreen C, Ahmed B, Roughead E et al. Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study. Pharmacoepidemiology and Drug Safety. 2022;31(S2):76-76.
Author
Morrow, Richard ; Mintzes, Barbara ; Souverein, Patrick ; Hallgreen, Christine ; Ahmed, Bilal ; Roughead, Elizabeth ; De Bruin, Marie Louise ; Kristiansen, Sarah ; Lexchin, Joel ; Kemp-Casey, Anna ; Sketris, Ingrid ; Mangin, Dee ; Pearson, Sallie-Anne ; Puil, Lorri ; Lopert, Ruth ; Bero, Lisa ; Gnjidic, Danijela ; Sarpatwari, Ameet ; Dormuth, Colin. / Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada : A longitudinal cohort study. In: Pharmacoepidemiology and Drug Safety. 2022 ; Vol. 31, No. S2. pp. 76-76.
Bibtex
@article{42fe2dc4501d4210a4b4492dc3a328a7,
title = "Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study",
author = "Richard Morrow and Barbara Mintzes and Patrick Souverein and Christine Hallgreen and Bilal Ahmed and Elizabeth Roughead and {De Bruin}, {Marie Louise} and Sarah Kristiansen and Joel Lexchin and Anna Kemp-Casey and Ingrid Sketris and Dee Mangin and Sallie-Anne Pearson and Lorri Puil and Ruth Lopert and Lisa Bero and Danijela Gnjidic and Ameet Sarpatwari and Colin Dormuth",
year = "2022",
language = "English",
volume = "31",
pages = "76--76",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "JohnWiley & Sons Ltd",
number = "S2",
note = "38th International Conference on Pharmacoepidemiology : Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community ; Conference date: 26-08-2022 Through 28-08-2022",
}
RIS
TY - ABST
T1 - Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada
T2 - 38th International Conference on Pharmacoepidemiology
AU - Morrow, Richard
AU - Mintzes, Barbara
AU - Souverein, Patrick
AU - Hallgreen, Christine
AU - Ahmed, Bilal
AU - Roughead, Elizabeth
AU - De Bruin, Marie Louise
AU - Kristiansen, Sarah
AU - Lexchin, Joel
AU - Kemp-Casey, Anna
AU - Sketris, Ingrid
AU - Mangin, Dee
AU - Pearson, Sallie-Anne
AU - Puil, Lorri
AU - Lopert, Ruth
AU - Bero, Lisa
AU - Gnjidic, Danijela
AU - Sarpatwari, Ameet
AU - Dormuth, Colin
N1 - Conference code: 38
PY - 2022
Y1 - 2022
M3 - Conference abstract in journal
VL - 31
SP - 76
EP - 76
JO - Pharmacoepidemiology and Drug Safety
JF - Pharmacoepidemiology and Drug Safety
SN - 1053-8569
IS - S2
Y2 - 26 August 2022 through 28 August 2022
ER -
